(NYSEMKT: OGEN) Oragenics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 70.22%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 39.81%.
Oragenics's earnings in 2026 is -$10,904,740.On average, 3 Wall Street analysts forecast OGEN's earnings for 2026 to be -$2,933,595, with the lowest OGEN earnings forecast at -$2,818,552, and the highest OGEN earnings forecast at -$3,019,878. On average, 3 Wall Street analysts forecast OGEN's earnings for 2027 to be -$1,785,667, with the lowest OGEN earnings forecast at -$1,715,641, and the highest OGEN earnings forecast at -$1,838,186.
In 2028, OGEN is forecast to generate -$1,658,119 in earnings, with the lowest earnings forecast at -$1,593,095 and the highest earnings forecast at -$1,706,887.